Use of the Impella 2.5 for prophylactic circulatory support during elective high-risk percutaneous coronary intervention

Cardiovascular Revascularization Medicine

Volumn 12, Issue 5, 2011, Pages 299-303

  Alasnag, Mirvat A ^a   Gardi, Delair O ^a   Elder, Mahir ^a   Kannam, Hari ^a   Ali, Farhan ^a   Petrina, Mircea ^a   Kheterpal, Vipin ^a   Hout, Mariah S ^b   Schreiber, Theodore L ^a  

^a HARPER UNIVERSITY HOSPITAL   (United States)

^b Abiomed   (United States)

Author keywords

High risk percutaneous coronary intervention; Impella 2.5; Mechanical circulatory support; Percutaneous left ventricular assist device

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; FIBRINOGEN RECEPTOR ANTAGONIST; HEPARIN; HIRULOG;

ACUTE CORONARY SYNDROME; AGED; ANGIOGRAPHY; ARTICLE; ASSISTED CIRCULATION; BLOOD PUMP; BYPASS SURGERY; CHRONIC LUNG DISEASE; CORONARY ARTERY RECANALIZATION; DIABETES MELLITUS; FEMALE; GROIN HEMATOMA; HEART INFARCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEMATOMA; HIGH RISK PATIENT; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MEDICAL SPECIALIST; MORTALITY; MULTIVESSEL DISEASE; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; RISK ASSESSMENT; VASCULAR DISEASE;

AGED; ANGIOPLASTY, BALLOON, CORONARY; CORONARY ANGIOGRAPHY; CORONARY STENOSIS; FEASIBILITY STUDIES; FEMALE; HEART-ASSIST DEVICES; HEMODYNAMICS; HUMANS; MALE; MICHIGAN; MIDDLE AGED; PROSTHESIS DESIGN; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SHOCK; TIME FACTORS; TREATMENT OUTCOME;

EID: 80052552087     PISSN: 15538389     EISSN: 18780938     Source Type: Journal    
DOI: 10.1016/j.carrev.2011.02.002     Document Type: Article

References (14)

1. Smith SC, Feldman TE, Hirshfeld JW, Jacobs AK, Kern MJ, King SB, Morrison DA, O'Neill WW, Schaff HV, Whitlow PL, Williams DO, Antman EM, Smith SC, Adams CD, Anderson JL, Faxon DP, Fuster V, Halperin JL, Hiratzka LF, Hunt SA, Jacobs AK, Nishimura R, Ornato JP, Page RL, Riegel B ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/SCAI Writing Committee to Update the 2001 Guidelines for Percutaneous Coronary Intervention). Circulation 2006, 113:e166-e286.
2. Dixon SR, Henriques JPS, Mauri L, Sjauw K, Civitello A, Kar B, Loyalka P, Resnic FS, Teirstein P, Makkar R, Palacios IF, Collins M, Moses J, Benali K, O'Neill WW A prospective feasibility trial investigating the use of the Impella 2.5 system in patients undergoing high-risk percutaneous coronary intervention (the PROTECT I trial): initial U.S. experience. J Am Coll Cardiol Intv 2009, 2:91-96.
3. Henriques JPS, Remmelink M, Baan J, van der Schaaf RJ, Vis MM, Koch KT, Scholten EW, de Mol BAJM, Tijssen JGP, Piek JJ, de Winter RJ Safety and feasibility of elective high-risk percutaneous coronary intervention procedures with left ventricular support of the Impella Recover LP 2.5. Am J Cardiol 2006, 97:990-992.
4. Burzotta F, Paloscia L, Trani C, Mascellanti M, Mongiardo R, Materazzo G, Niccoli G, Di Marco M, Leone AM, Porto I, Mazzari MA, Rebuzzi AG, Schiavoni G, Crea F Feasibility and long-term safety of elective Impella-assisted high-risk percutaneous coronary intervention: a pilot two-centre study. J Cardiovasc Med 2008, 9:1004-1010.
5. Sjauw KD, Konorza T, Erbel R, Danna PL, Viecca M, Minden HH, Butter C, Engstrom T, Hassager C, Machado FP, Pedrazzini G, Wagner DR, Schamberger R, Kerber S, Mathey DG, Schofer J, Engstrom AE, Henriques JPS Supported high-risk percutaneous coronary intervention with the Impella 2.5 device. J Am Coll Cardiol 2009, 54:2430-2434.
6. Trindade IS, Sarmento-Leite R, Santos de Freitas M, Gottschall CA Determination of the minimum inflation time necessary for total stent expansion and apposition: an in vitro study. J Invasive Cardiol 2008, 20:396-398.
7. Briguori C, Sarais C, Pagnotta P, Airoldi F, Liistro F, Sgura F, Spanos V, Carlino M, Montorfano M, Di Mario C, Colombo A Elective versus provisional intra-aortic balloon pumping in high-risk percutaneous transluminal coronary angioplasty. Am Heart J 2003, 145:700-707.
8. Seyfarth M, Sibbing D, Bauer I, Fröhlich G, Bott-Flügel L, Byrne R, Dirschinger J, Kastrati A, Schömig A A randomized clinical trial to evaluate the safety and efficacy of a percutaneous left ventricular assist device versus intra-aortic balloon pumping for treatment of cardiogenic shock caused by myocardial infarction. J Am Coll Cardiol 2008, 52:1584-1588.
9. Schreiber TL, Kodali UR, O'Neill WW, Gangadharan V, Puchrowicz-Ochocki SB, Grines CL Comparison of acute results of prophylactic intraaortic balloon pumping with cardiopulmonary support for percutaneous transluminal coronary angioplasty (PTCA). Cathet Cardiovasc Diagn 1998, 45:115-119.
10. Vranckx P, Schultz CJ, Valmigli M, Eindhoven JA, Kappetein AP, Regar ES, Van Domburg R, Serruys PW Assisted circulation using the Tandemheart during very high-risk PCI of the unprotected left main coronary artery in patients declined for CABG. Cathet Cardiovasc Interv 2009, 74:302-310.
11. Valgimigli M, Steendijk P, Sianos G, Onderwater E, Serruys PW Left ventricular unloading and concomitant total cardiac output increase by the use of percutaneous Impella Recover LP 2.5 assist device during high-risk coronary intervention. Cathet Cardiovasc Interv 2005, 65:263-267.
12. Remmelink M, Sjauw KD, Henriques JPS, de Winter RJ, Koch KT, van der Schaaf RJ, Vis MM, Tijssen JGP, Piek JJ, Baan J Effects of left ventricular unloading by Impella Recover LP2.5 on coronary hemodynamics. Cathet Cardiovasc Interv 2007, 70:532-537.
13. Mishra S, Chu WW, Torguson R, Wolfram R, Deible R, Suddath WO, Pichard AD, Satler LF, Kent KM, Waksman R Role of prophylactic intra-aortic balloon pump in high-risk patients undergoing percutaneous coronary intervention. Am J Cardiol 2006, 98:608-612.
14. Briguori C, Airoldi F, Chieffo A, Montorfano M, Carlino M, Massimo Sangiorgi G, Morici N, Michev I, Iakovou I, Biondi-Zoccai G, Colombo A Elective versus provisional intraaortic balloon pumping in unprotected left main stenting. Am Heart J 2006, 152:565-572.